Penn Capital Special Sits Sm Cp Eq Inst holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
Penn Capital Special Situations Small Cap Equity Fund Institutional Class PSCNX
- NAV / 1-Day Return 19.45 / −3.52 %
- Total Assets 107.2M
-
Adj. Expense Ratio
1.090%
- Expense Ratio 1.090%
- Distribution Fee Level High
- Share Class Type Institutional
- Category Small Blend
- Investment Style Small Blend
- Min. Initial Investment 2,500
- Status Open
- TTM Yield 0.00
- Turnover 91%
USD | NAV as of Jun 06, 2026 | 1-Day Return as of Jun 06, 2026, 2:45 AM GMT+0
Morningstar’s Analysis PSCNX
Will PSCNX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the PSCNX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of PSCNX’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 17.4
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Ouster Inc Ordinary Shares - Class A | 2.04 | 2M | Technology |
RXO Inc | 1.96 | 2M | Industrials |
Legence Corp Ordinary Shares - Class A | 1.90 | 2M | Industrials |
ACM Research Inc Class A | 1.68 | 2M | Technology |
The Chemours Co | 1.67 | 2M | Basic Materials |
Mirum Pharmaceuticals Inc | 1.66 | 2M | Healthcare |
Weatherford International PLC Ordinary Shares - New | 1.63 | 2M | Energy |
Constellium SE Class A | 1.63 | 2M | Basic Materials |
Ligand Pharmaceuticals Inc | 1.62 | 2M | Healthcare |
Caesars Entertainment Inc | 1.61 | 2M | Consumer Cyclical |
United States